To include your compound in the COVID-19 Resource Center, submit it here.

Bydureon exenatide once weekly: QT/QTc study data

Amylin previously reported data from a QT analysis of its twice-daily diabetes drug Byetta exenatide suggesting that the QTc interval is not prolonged by more than 5 ms, even at plasma concentrations above 300 pg/mL (see

Read the full 360 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers